Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Transaction in Own Shares

5 Mar 2024 17:48

RNS Number : 7111F
NatWest Group plc
05 March 2024
 

NatWest Group plc

 

5 March 2024

Transaction in Own Shares

 

NatWest Group plc (the 'Company') announces today that it has purchased the following number of ordinary shares in the Company with a nominal value of £1.0769* each ('Ordinary Shares') from UBS AG, London Branch ('UBS') across two transactions, Transaction 1 and Transaction 2 (together the 'Transactions').

The purchases form part of the Company's existing share buyback programmes, with Transaction 1 purchases effected pursuant to the instructions issued by the Company to UBS on 28 July 2023, as announced on 31 July 2023 and Transaction 2 purchases effected pursuant to the instructions issued by the Company to UBS on 16 February 2024, as announced on 19 February 2024.

Aggregated information relating to the Transactions is set out in the tables below.

Transaction 1:

 

Date of purchase

Number of Ordinary Shares purchased

Highest price paid: (GBp)

Lowest price paid: (GBp)

Volume weighted average price paid per share (GBp)

Venue

05 March 2024

0

0.00

0.00

0.0000

LSE

05 March 2024

0

0.00

0.00

0.0000

CHIX

05 March 2024

0

0.00

0.00

0.0000

BATE

Transaction 2:

 

Date of purchase

Number of Ordinary Shares purchased

Highest price paid: (GBp)

Lowest price paid: (GBp)

Volume weighted average price paid per share (GBp)

Venue

05 March 2024

4,116

247.20

247.00

247.0941

LSE

05 March 2024

1,438

246.60

246.60

246.6000

CHIX

05 March 2024

3,963

246.80

245.90

246.4235

BATE

* Note: the nominal value of Ordinary Shares without rounding is £1.076923076923077 per share

The Company intends to cancel all of the Ordinary Shares repurchased under the Transactions. Following the settlement of the transactions, the Company will hold 173,916,442 Ordinary Shares in treasury and have 8,750,878,369 Ordinary Shares in issue (excluding treasury shares).

Further information:

Investor Relations

+ 44 (0)207 672 1758

Media Relations

+44 (0)131 523 4205

Legal Entity Identifier: 2138005O9XJIJN4JPN90

Details of the Transactions

 

In accordance with Article 5(1)(b) of Regulation (EU) No.596/2014 as it applies in the UK (Market Abuse Regulation), a full breakdown of the individual trades made by UBS on behalf of the Company as part of the buyback programmes relating to the Transactions is detailed below:

Transaction 2:

 

Transaction Date

Time

Time Zone

Volume (shares)

Price (GBp)

Trading Venue

MatchID

05 March 2024

08:01:09

BST

1438

246.60

CHIX

1687796

05 March 2024

08:00:35

BST

769

245.90

BATE

1687090

05 March 2024

08:00:32

BST

504

246.20

BATE

1687019

05 March 2024

08:00:32

BST

995

246.30

BATE

1687017

05 March 2024

08:00:32

BST

881

246.80

BATE

1687012

05 March 2024

08:00:32

BST

814

246.80

BATE

1687010

05 March 2024

08:00:30

BST

2

247.00

LSE

1686969

05 March 2024

08:00:30

BST

1023

247.10

LSE

1686966

05 March 2024

08:00:30

BST

989

247.20

LSE

1686955

05 March 2024

08:00:30

BST

1231

247.00

LSE

1686945

05 March 2024

08:00:29

BST

871

247.10

LSE

1686854

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSQKPBQOBKDANK

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.